REKOVER study protocol: a pRospective patient treatment rEgistry of tramadol and dexKetoprofen trometamol oral fixed-dose combination (SKUDEXA) in mOderate to seVere acutE pain in Real-world setting in Asia

Kok Yuen Ho,Bibek Gyanwali,Cesar Dimayuga,Edgar Michael Eufemio,Edwin Bernardo,Gopinathan Raju,Keen Wai Chong,Kritsadakorn Waithayayothin,Leonardo Ona,Marc Anthony L Castro,Passakorn Sawaddiruk,Roehl C Salvador,Sharifah Ahmad Roohi,Suwimon Tangwiwat,Vajara Wilairatana,Zhi Hao Oon,Ankur Gupta,Dinesh Nagrale

doi:10.1136/bmjopen-2023-080620

REKOVER study protocol: a pRospective patient treatment rEgistry of tramadol and dexKetoprofen trometamol oral fixed-dose combination (SKUDEXA) in mOderate to seVere acutE pain in Real-world setting in Asia

Kok Yuen Ho, Bibek Gyanwali + Show 16 more

Open Access

https://doi.org/10.1136/bmjopen-2023-080620

Copy DOI

Journal: BMJ Open	Publication Date: Mar 1, 2024
License type: CC BY-NC 4.0

#Fixed-dose Combination #Dexketoprofen Trometamol + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionSatisfactory management of acute pain remains a major medical challenge despite the availability of multiple therapeutic options including the fixed-dose combination (FDC) drugs. Tramadol and dexketoprofen trometamol (TRAM/DKP) 75/25 mg...

Full Text